CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 22,000 enrolled
Drug / intervention
Daily 500 mg elemental calcium as calcium carbonate +1 moredietary
Likely dose
Daily 500 mg elemental calcium as calcium carbonatefrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03350516
NCT03350516Phase 3Completed

Demonstrating Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy for Reducing Preeclampsia and Neonatal Outcomes

Harvard School of Public Health (HSPH)·interventional·Posted Nov 22, 2017·Updated Dec 24, 2024

In Brief

A Phase 3 clinical trial evaluating Daily 500 mg elemental calcium as calcium carbonate and Daily1500 mg elemental calcium as calcium carbonate for Pregnancy Related. Completed, enrolled 22,000 participants across 3 sites in 2 countries.

Detailed Summary

The World Health Organization currently recommends that pregnant women in populations with low calcium intake receive daily calcium supplementation (1500 - 2000 mg) divided into three doses which are preferably taken at mealtimes, in addition to daily iron folic-acid supplements. Despite proven efficacy and the WHO recommendation, calcium supplementation in pregnancy is not standard of care in the vast majority of low-income and middle-income countries. Two important barriers to implementation are the cost of the supplements and complexity of the suggested calcium dosing schedule. A lower dose of calcium (500 mg) administered as a single dose has been shown to be beneficial in several trials, and if found to be as effective as the 1500 mg supplementation regimen, it may help overcome these barriers and increase individual and health system adoption. The Investigators will conduct two parallel, individually randomized, double blind non-inferiority trials in India and Tanzania. Participating pregnant woman will be randomized to either 1500 mg or 500 mg calcium supplementation. The India and Tanzania trials are independently powered for the primary outcomes of i) preeclampsia and ii) preterm birth. The India and Tanzania sites will each enroll 11,000 participants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesIndia, Tanzania

Timeline

Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedNov 22, 2017
Enrollment StartNov 30, 2018
Primary CompletionNov 3, 2022
Study CompletionDec 16, 2022
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 8.6 years ago

Interventions

Daily 500 mg elemental calcium as calcium carbonatedietary

Pregnant women in this arm will be provided and counselled to take three tablets, one containing 500 mg elemental calcium as calcium carbonate and 2 placebo supplements daily (total of 500 mg daily). The supplements in India will also contain 83.3 IU each of vitamin D3, for a total of 250 IU daily. No vitamin D3 will be given in Tanzania.

Daily1500 mg elemental calcium as calcium carbonatedietary

Pregnant women in this arm will be provided and counselled to take three tablets each containing 500 mg elemental calcium as calcium carbonate daily (total of 1500 mg daily) as currently recommended by the World Health Organization. The supplements in India will also contain 83.3 IU each of vitamin D3, for a total of 250 IU daily. No vitamin D3 will be given in Tanzania.